Halozyme Therapeutics, Inc. (HALO) Estimates

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Revenue Estimates

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 231.35 M290.08 M298.01 M264.86 M325.72 M354.26 M451.77 M376.71 M-------------------
High Estimate 211.91 M265.13 M298.74 M236.97 M301.63 M365.73 M439.17 M406.48 M456.81 M529.32 M545.66 M476.12 M545.70 M564.28 M657.70 M458.72 M544.35 M652.50 M721.28 M499.59 M516.54 M517.31 M608.86 M606.20 M632.47 M709.60 M892.12 M
Low Estimate 180.77 M225.15 M246.86 M204.54 M247.05 M339.84 M393.87 M354.72 M390.31 M440.99 M477.17 M422.53 M484.06 M513.58 M551.94 M407.70 M503.69 M541.63 M628.38 M414.15 M448.10 M455.59 M500.07 M560.96 M561.68 M590.05 M762.50 M
Consensus Estimate 196.34 M245.14 M272.80 M220.75 M274.34 M352.78 M416.52 M380.60 M423.56 M485.15 M511.41 M449.33 M514.88 M538.93 M604.82 M433.21 M524.02 M597.07 M674.83 M456.87 M482.32 M486.45 M554.47 M583.58 M597.07 M649.82 M827.31 M

Earnings Per Share (EPS) Estimates

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 0.911.271.261.111.541.72-0.241.60-------------------
High Estimate 0.811.021.280.991.471.842.361.582.002.482.672.542.633.043.023.022.883.412.822.792.762.752.283.013.153.272.76
Low Estimate 0.670.861.100.851.211.642.181.301.702.122.272.182.432.642.582.522.422.792.382.572.522.472.022.752.672.932.56
Consensus Estimate 0.740.941.190.921.341.742.271.441.852.302.472.362.532.842.802.772.653.102.602.682.642.612.152.882.913.102.66